Answer
Octreotide acetate inhibits pathologically increased GH and GEP peptide/serotonin secretion; in healthy subjects, Sandostatin inhibits arginine-, exercise- and insulin-induced hypoglycaemia-stimulated GH, postprandial insulin, glucagon, gastrin and other GEP peptides, arginine-stimulated insulin and glucagon, and TRH-stimulated TSH release.
Sources for this answer
- Sandostatin 50, 100, 500 microgram/1 ml solution for injection/infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 27Document updated
Sources checked